SMARTSTEP

SmartStep Consulting GmbH

@smartstep_consulting

Hamburg, Hamburg
https://www.smartstep-consulting.de/en
Business Consulting and Services

Overview

About SmartStep Consulting GmbH

With over 15 years of proven expertise in Market Access, SmartStep provides highly specialized and individualized consulting for the pharmaceutical, vaccine, and biotech industry. We support our clients in achieving, defending, and maintaining fast, efficient, and evidence-based Market Access for their products.

As one of the early pioneers, we introduced Artificial Intelligence into Medical Writing and Dossier Development – applying advanced technologies to increase efficiency, quality, and innovation at a time when the industry was only beginning to explore such approaches. This forward-thinking mindset, combined with our deep scientific and strategic knowledge, enables us to deliver tailored solutions that anticipate challenges and maximize value for patients, healthcare systems, and manufacturers alike.

SmartStep stand for excellence, agility, and partnership – ensuring that every product has the best possible path to successful and sustainable Market Access. Building on this strong foundation, we are pursuing continuous growth and internationalization – expanding our network, capabilities, and partnerships to serve clients across Europe and beyond. Because for us, Market Access is never just about products – it is about making sure every patient gets timely access to the right therapy at the right value.

IMPRINT: https://www.smartstep-consulting.de/en/legal-notice/
PRIVACY POLICY: https://www.smartstep-consulting.de/en/data-protection/

Headquarters

Hamburg, Hamburg

Website

https://www.smartstep-consulting.de/en

Company Size

51-200 employees

Industry

Business Consulting and Services

Company Type

Public Company

Founded

2010

Specialties

Market Access, Statistics, Healthcare Strategy Consulting, Biotech, Contract Management, Submissions, Dossier, Patient Reported Outcomes (PRO), Medical Writing, Real World Evidence (RWE), EU Health Technology Assessment (HTA), Health Economics and Outcomes Research (HEOR), Joint Clinical Assessment (JCA), Price Negotiation, Joint Scientific Consultation (JSC), AMNOG, Pricing & Reimbursement, Advanced Therapy Medicinal Products (ATMP), Systematic Literature Reviews (SLR), and Orphan Drugs

Posts